Global Lung Cancer Diagnostics Market Research Report 2024, Forecast to 2032
Report Overview
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
The global Lung Cancer Diagnostics market size was estimated at USD 1883.50 million in 2023 and is projected to reach USD 3101.99 million by 2032, exhibiting a CAGR of 5.70% during the forecast period.
North America Lung Cancer Diagnostics market size was estimated at USD 539.91 million in 2023, at a CAGR of 4.89% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Lung Cancer Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Diagnostics market in any manner.
Global Lung Cancer Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche Diagnostics
BioMйrieux
Qiagen
Advpharma
AIT Austrian Institute of Technology
Courtagen Life Sciences
DiagnoCure
BioMark Diagnostics
Mayo Clinic
HalioDx SAS
Market Segmentation (by Type)
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other
Market Segmentation (by Application)
Industrial
Healthcare
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Lung Cancer Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
The global Lung Cancer Diagnostics market size was estimated at USD 1883.50 million in 2023 and is projected to reach USD 3101.99 million by 2032, exhibiting a CAGR of 5.70% during the forecast period.
North America Lung Cancer Diagnostics market size was estimated at USD 539.91 million in 2023, at a CAGR of 4.89% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Lung Cancer Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Diagnostics market in any manner.
Global Lung Cancer Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche Diagnostics
BioMйrieux
Qiagen
Advpharma
AIT Austrian Institute of Technology
Courtagen Life Sciences
DiagnoCure
BioMark Diagnostics
Mayo Clinic
HalioDx SAS
Market Segmentation (by Type)
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other
Market Segmentation (by Application)
Industrial
Healthcare
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Lung Cancer Diagnostics Market
- Overview of the regional outlook of the Lung Cancer Diagnostics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Lung Cancer Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostics
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostics Segment by Type
1.2.2 Lung Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Lung Cancer Diagnostics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Lung Cancer Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Lung Cancer Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lung Cancer Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lung Cancer Diagnostics Sales Sites, Area Served, Product Type
3.6 Lung Cancer Diagnostics Market Competitive Situation and Trends
3.6.1 Lung Cancer Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LUNG CANCER DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Lung Cancer Diagnostics Price by Type (2019-2024)
7 LUNG CANCER DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostics Market Sales by Application (2019-2024)
7.3 Global Lung Cancer Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Lung Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
8 LUNG CANCER DIAGNOSTICS MARKET CONSUMPTION BY REGION
8.1 Global Lung Cancer Diagnostics Sales by Region
8.1.1 Global Lung Cancer Diagnostics Sales by Region
8.1.2 Global Lung Cancer Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 LUNG CANCER DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Lung Cancer Diagnostics by Region (2019-2024)
9.2 Global Lung Cancer Diagnostics Revenue Market Share by Region (2019-2024)
9.3 Global Lung Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Lung Cancer Diagnostics Production
9.4.1 North America Lung Cancer Diagnostics Production Growth Rate (2019-2024)
9.4.2 North America Lung Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Lung Cancer Diagnostics Production
9.5.1 Europe Lung Cancer Diagnostics Production Growth Rate (2019-2024)
9.5.2 Europe Lung Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Lung Cancer Diagnostics Production (2019-2024)
9.6.1 Japan Lung Cancer Diagnostics Production Growth Rate (2019-2024)
9.6.2 Japan Lung Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Lung Cancer Diagnostics Production (2019-2024)
9.7.1 China Lung Cancer Diagnostics Production Growth Rate (2019-2024)
9.7.2 China Lung Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche Diagnostics
10.1.1 Roche Diagnostics Lung Cancer Diagnostics Basic Information
10.1.2 Roche Diagnostics Lung Cancer Diagnostics Product Overview
10.1.3 Roche Diagnostics Lung Cancer Diagnostics Product Market Performance
10.1.4 Roche Diagnostics Business Overview
10.1.5 Roche Diagnostics Lung Cancer Diagnostics SWOT Analysis
10.1.6 Roche Diagnostics Recent Developments
10.2 BioMйrieux
10.2.1 BioMйrieux Lung Cancer Diagnostics Basic Information
10.2.2 BioMйrieux Lung Cancer Diagnostics Product Overview
10.2.3 BioMйrieux Lung Cancer Diagnostics Product Market Performance
10.2.4 BioMйrieux Business Overview
10.2.5 BioMйrieux Lung Cancer Diagnostics SWOT Analysis
10.2.6 BioMйrieux Recent Developments
10.3 Qiagen
10.3.1 Qiagen Lung Cancer Diagnostics Basic Information
10.3.2 Qiagen Lung Cancer Diagnostics Product Overview
10.3.3 Qiagen Lung Cancer Diagnostics Product Market Performance
10.3.4 Qiagen Lung Cancer Diagnostics SWOT Analysis
10.3.5 Qiagen Business Overview
10.3.6 Qiagen Recent Developments
10.4 Advpharma
10.4.1 Advpharma Lung Cancer Diagnostics Basic Information
10.4.2 Advpharma Lung Cancer Diagnostics Product Overview
10.4.3 Advpharma Lung Cancer Diagnostics Product Market Performance
10.4.4 Advpharma Business Overview
10.4.5 Advpharma Recent Developments
10.5 AIT Austrian Institute of Technology
10.5.1 AIT Austrian Institute of Technology Lung Cancer Diagnostics Basic Information
10.5.2 AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Overview
10.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Market Performance
10.5.4 AIT Austrian Institute of Technology Business Overview
10.5.5 AIT Austrian Institute of Technology Recent Developments
10.6 Courtagen Life Sciences
10.6.1 Courtagen Life Sciences Lung Cancer Diagnostics Basic Information
10.6.2 Courtagen Life Sciences Lung Cancer Diagnostics Product Overview
10.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Product Market Performance
10.6.4 Courtagen Life Sciences Business Overview
10.6.5 Courtagen Life Sciences Recent Developments
10.7 DiagnoCure
10.7.1 DiagnoCure Lung Cancer Diagnostics Basic Information
10.7.2 DiagnoCure Lung Cancer Diagnostics Product Overview
10.7.3 DiagnoCure Lung Cancer Diagnostics Product Market Performance
10.7.4 DiagnoCure Business Overview
10.7.5 DiagnoCure Recent Developments
10.8 BioMark Diagnostics
10.8.1 BioMark Diagnostics Lung Cancer Diagnostics Basic Information
10.8.2 BioMark Diagnostics Lung Cancer Diagnostics Product Overview
10.8.3 BioMark Diagnostics Lung Cancer Diagnostics Product Market Performance
10.8.4 BioMark Diagnostics Business Overview
10.8.5 BioMark Diagnostics Recent Developments
10.9 Mayo Clinic
10.9.1 Mayo Clinic Lung Cancer Diagnostics Basic Information
10.9.2 Mayo Clinic Lung Cancer Diagnostics Product Overview
10.9.3 Mayo Clinic Lung Cancer Diagnostics Product Market Performance
10.9.4 Mayo Clinic Business Overview
10.9.5 Mayo Clinic Recent Developments
10.10 HalioDx SAS
10.10.1 HalioDx SAS Lung Cancer Diagnostics Basic Information
10.10.2 HalioDx SAS Lung Cancer Diagnostics Product Overview
10.10.3 HalioDx SAS Lung Cancer Diagnostics Product Market Performance
10.10.4 HalioDx SAS Business Overview
10.10.5 HalioDx SAS Recent Developments
11 LUNG CANCER DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Lung Cancer Diagnostics Market Size Forecast
11.2 Global Lung Cancer Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lung Cancer Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Lung Cancer Diagnostics Market Size Forecast by Region
11.2.4 South America Lung Cancer Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Lung Cancer Diagnostics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Lung Cancer Diagnostics by Type (2025-2032)
12.1.2 Global Lung Cancer Diagnostics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Lung Cancer Diagnostics by Type (2025-2032)
12.2 Global Lung Cancer Diagnostics Market Forecast by Application (2025-2032)
12.2.1 Global Lung Cancer Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Lung Cancer Diagnostics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostics
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostics Segment by Type
1.2.2 Lung Cancer Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Lung Cancer Diagnostics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Lung Cancer Diagnostics Sales by Manufacturers (2019-2024)
3.2 Global Lung Cancer Diagnostics Revenue Market Share by Manufacturers (2019-2024)
3.3 Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lung Cancer Diagnostics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lung Cancer Diagnostics Sales Sites, Area Served, Product Type
3.6 Lung Cancer Diagnostics Market Competitive Situation and Trends
3.6.1 Lung Cancer Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lung Cancer Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 LUNG CANCER DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostics Sales Market Share by Type (2019-2024)
6.3 Global Lung Cancer Diagnostics Market Size Market Share by Type (2019-2024)
6.4 Global Lung Cancer Diagnostics Price by Type (2019-2024)
7 LUNG CANCER DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostics Market Sales by Application (2019-2024)
7.3 Global Lung Cancer Diagnostics Market Size (M USD) by Application (2019-2024)
7.4 Global Lung Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
8 LUNG CANCER DIAGNOSTICS MARKET CONSUMPTION BY REGION
8.1 Global Lung Cancer Diagnostics Sales by Region
8.1.1 Global Lung Cancer Diagnostics Sales by Region
8.1.2 Global Lung Cancer Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 LUNG CANCER DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Lung Cancer Diagnostics by Region (2019-2024)
9.2 Global Lung Cancer Diagnostics Revenue Market Share by Region (2019-2024)
9.3 Global Lung Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Lung Cancer Diagnostics Production
9.4.1 North America Lung Cancer Diagnostics Production Growth Rate (2019-2024)
9.4.2 North America Lung Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Lung Cancer Diagnostics Production
9.5.1 Europe Lung Cancer Diagnostics Production Growth Rate (2019-2024)
9.5.2 Europe Lung Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Lung Cancer Diagnostics Production (2019-2024)
9.6.1 Japan Lung Cancer Diagnostics Production Growth Rate (2019-2024)
9.6.2 Japan Lung Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Lung Cancer Diagnostics Production (2019-2024)
9.7.1 China Lung Cancer Diagnostics Production Growth Rate (2019-2024)
9.7.2 China Lung Cancer Diagnostics Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche Diagnostics
10.1.1 Roche Diagnostics Lung Cancer Diagnostics Basic Information
10.1.2 Roche Diagnostics Lung Cancer Diagnostics Product Overview
10.1.3 Roche Diagnostics Lung Cancer Diagnostics Product Market Performance
10.1.4 Roche Diagnostics Business Overview
10.1.5 Roche Diagnostics Lung Cancer Diagnostics SWOT Analysis
10.1.6 Roche Diagnostics Recent Developments
10.2 BioMйrieux
10.2.1 BioMйrieux Lung Cancer Diagnostics Basic Information
10.2.2 BioMйrieux Lung Cancer Diagnostics Product Overview
10.2.3 BioMйrieux Lung Cancer Diagnostics Product Market Performance
10.2.4 BioMйrieux Business Overview
10.2.5 BioMйrieux Lung Cancer Diagnostics SWOT Analysis
10.2.6 BioMйrieux Recent Developments
10.3 Qiagen
10.3.1 Qiagen Lung Cancer Diagnostics Basic Information
10.3.2 Qiagen Lung Cancer Diagnostics Product Overview
10.3.3 Qiagen Lung Cancer Diagnostics Product Market Performance
10.3.4 Qiagen Lung Cancer Diagnostics SWOT Analysis
10.3.5 Qiagen Business Overview
10.3.6 Qiagen Recent Developments
10.4 Advpharma
10.4.1 Advpharma Lung Cancer Diagnostics Basic Information
10.4.2 Advpharma Lung Cancer Diagnostics Product Overview
10.4.3 Advpharma Lung Cancer Diagnostics Product Market Performance
10.4.4 Advpharma Business Overview
10.4.5 Advpharma Recent Developments
10.5 AIT Austrian Institute of Technology
10.5.1 AIT Austrian Institute of Technology Lung Cancer Diagnostics Basic Information
10.5.2 AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Overview
10.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Market Performance
10.5.4 AIT Austrian Institute of Technology Business Overview
10.5.5 AIT Austrian Institute of Technology Recent Developments
10.6 Courtagen Life Sciences
10.6.1 Courtagen Life Sciences Lung Cancer Diagnostics Basic Information
10.6.2 Courtagen Life Sciences Lung Cancer Diagnostics Product Overview
10.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Product Market Performance
10.6.4 Courtagen Life Sciences Business Overview
10.6.5 Courtagen Life Sciences Recent Developments
10.7 DiagnoCure
10.7.1 DiagnoCure Lung Cancer Diagnostics Basic Information
10.7.2 DiagnoCure Lung Cancer Diagnostics Product Overview
10.7.3 DiagnoCure Lung Cancer Diagnostics Product Market Performance
10.7.4 DiagnoCure Business Overview
10.7.5 DiagnoCure Recent Developments
10.8 BioMark Diagnostics
10.8.1 BioMark Diagnostics Lung Cancer Diagnostics Basic Information
10.8.2 BioMark Diagnostics Lung Cancer Diagnostics Product Overview
10.8.3 BioMark Diagnostics Lung Cancer Diagnostics Product Market Performance
10.8.4 BioMark Diagnostics Business Overview
10.8.5 BioMark Diagnostics Recent Developments
10.9 Mayo Clinic
10.9.1 Mayo Clinic Lung Cancer Diagnostics Basic Information
10.9.2 Mayo Clinic Lung Cancer Diagnostics Product Overview
10.9.3 Mayo Clinic Lung Cancer Diagnostics Product Market Performance
10.9.4 Mayo Clinic Business Overview
10.9.5 Mayo Clinic Recent Developments
10.10 HalioDx SAS
10.10.1 HalioDx SAS Lung Cancer Diagnostics Basic Information
10.10.2 HalioDx SAS Lung Cancer Diagnostics Product Overview
10.10.3 HalioDx SAS Lung Cancer Diagnostics Product Market Performance
10.10.4 HalioDx SAS Business Overview
10.10.5 HalioDx SAS Recent Developments
11 LUNG CANCER DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Lung Cancer Diagnostics Market Size Forecast
11.2 Global Lung Cancer Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lung Cancer Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Lung Cancer Diagnostics Market Size Forecast by Region
11.2.4 South America Lung Cancer Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Lung Cancer Diagnostics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Lung Cancer Diagnostics by Type (2025-2032)
12.1.2 Global Lung Cancer Diagnostics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Lung Cancer Diagnostics by Type (2025-2032)
12.2 Global Lung Cancer Diagnostics Market Forecast by Application (2025-2032)
12.2.1 Global Lung Cancer Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Lung Cancer Diagnostics Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Lung Cancer Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Lung Cancer Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Lung Cancer Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostics as of 2022)
Table 10. Global Market Lung Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Lung Cancer Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Diagnostics Product Type
Table 13. Global Lung Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Lung Cancer Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lung Cancer Diagnostics Market Challenges
Table 22. Global Lung Cancer Diagnostics Sales by Type (K Units)
Table 23. Global Lung Cancer Diagnostics Market Size by Type (M USD)
Table 24. Global Lung Cancer Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Lung Cancer Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Lung Cancer Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Lung Cancer Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Lung Cancer Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Lung Cancer Diagnostics Sales (K Units) by Application
Table 30. Global Lung Cancer Diagnostics Market Size by Application
Table 31. Global Lung Cancer Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Lung Cancer Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Lung Cancer Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Lung Cancer Diagnostics Market Share by Application (2019-2024)
Table 35. Global Lung Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Lung Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Lung Cancer Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Lung Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Lung Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Lung Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Lung Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Lung Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Global Lung Cancer Diagnostics Production (K Units) by Region (2019-2024)
Table 44. Global Lung Cancer Diagnostics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Lung Cancer Diagnostics Revenue Market Share by Region (2019-2024)
Table 46. Global Lung Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Lung Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Lung Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Lung Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Lung Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Roche Diagnostics Lung Cancer Diagnostics Basic Information
Table 52. Roche Diagnostics Lung Cancer Diagnostics Product Overview
Table 53. Roche Diagnostics Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Roche Diagnostics Business Overview
Table 55. Roche Diagnostics Lung Cancer Diagnostics SWOT Analysis
Table 56. Roche Diagnostics Recent Developments
Table 57. BioMйrieux Lung Cancer Diagnostics Basic Information
Table 58. BioMйrieux Lung Cancer Diagnostics Product Overview
Table 59. BioMйrieux Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. BioMйrieux Business Overview
Table 61. BioMйrieux Lung Cancer Diagnostics SWOT Analysis
Table 62. BioMйrieux Recent Developments
Table 63. Qiagen Lung Cancer Diagnostics Basic Information
Table 64. Qiagen Lung Cancer Diagnostics Product Overview
Table 65. Qiagen Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Qiagen Lung Cancer Diagnostics SWOT Analysis
Table 67. Qiagen Business Overview
Table 68. Qiagen Recent Developments
Table 69. Advpharma Lung Cancer Diagnostics Basic Information
Table 70. Advpharma Lung Cancer Diagnostics Product Overview
Table 71. Advpharma Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Advpharma Business Overview
Table 73. Advpharma Recent Developments
Table 74. AIT Austrian Institute of Technology Lung Cancer Diagnostics Basic Information
Table 75. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Overview
Table 76. AIT Austrian Institute of Technology Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. AIT Austrian Institute of Technology Business Overview
Table 78. AIT Austrian Institute of Technology Recent Developments
Table 79. Courtagen Life Sciences Lung Cancer Diagnostics Basic Information
Table 80. Courtagen Life Sciences Lung Cancer Diagnostics Product Overview
Table 81. Courtagen Life Sciences Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Courtagen Life Sciences Business Overview
Table 83. Courtagen Life Sciences Recent Developments
Table 84. DiagnoCure Lung Cancer Diagnostics Basic Information
Table 85. DiagnoCure Lung Cancer Diagnostics Product Overview
Table 86. DiagnoCure Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. DiagnoCure Business Overview
Table 88. DiagnoCure Recent Developments
Table 89. BioMark Diagnostics Lung Cancer Diagnostics Basic Information
Table 90. BioMark Diagnostics Lung Cancer Diagnostics Product Overview
Table 91. BioMark Diagnostics Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. BioMark Diagnostics Business Overview
Table 93. BioMark Diagnostics Recent Developments
Table 94. Mayo Clinic Lung Cancer Diagnostics Basic Information
Table 95. Mayo Clinic Lung Cancer Diagnostics Product Overview
Table 96. Mayo Clinic Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Mayo Clinic Business Overview
Table 98. Mayo Clinic Recent Developments
Table 99. HalioDx SAS Lung Cancer Diagnostics Basic Information
Table 100. HalioDx SAS Lung Cancer Diagnostics Product Overview
Table 101. HalioDx SAS Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. HalioDx SAS Business Overview
Table 103. HalioDx SAS Recent Developments
Table 104. Global Lung Cancer Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 105. Global Lung Cancer Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Lung Cancer Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 107. North America Lung Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Lung Cancer Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 109. Europe Lung Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Lung Cancer Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 111. Asia Pacific Lung Cancer Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Lung Cancer Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 113. South America Lung Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Lung Cancer Diagnostics Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Lung Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Lung Cancer Diagnostics Sales Forecast by Type (2025-2032) & (K Units)
Table 117. Global Lung Cancer Diagnostics Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Lung Cancer Diagnostics Price Forecast by Type (2025-2032) & (USD/Unit)
Table 119. Global Lung Cancer Diagnostics Sales (K Units) Forecast by Application (2025-2032)
Table 120. Global Lung Cancer Diagnostics Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Diagnostics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Lung Cancer Diagnostics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Lung Cancer Diagnostics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Lung Cancer Diagnostics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostics as of 2022)
Table 10. Global Market Lung Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Lung Cancer Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Diagnostics Product Type
Table 13. Global Lung Cancer Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Lung Cancer Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lung Cancer Diagnostics Market Challenges
Table 22. Global Lung Cancer Diagnostics Sales by Type (K Units)
Table 23. Global Lung Cancer Diagnostics Market Size by Type (M USD)
Table 24. Global Lung Cancer Diagnostics Sales (K Units) by Type (2019-2024)
Table 25. Global Lung Cancer Diagnostics Sales Market Share by Type (2019-2024)
Table 26. Global Lung Cancer Diagnostics Market Size (M USD) by Type (2019-2024)
Table 27. Global Lung Cancer Diagnostics Market Size Share by Type (2019-2024)
Table 28. Global Lung Cancer Diagnostics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Lung Cancer Diagnostics Sales (K Units) by Application
Table 30. Global Lung Cancer Diagnostics Market Size by Application
Table 31. Global Lung Cancer Diagnostics Sales by Application (2019-2024) & (K Units)
Table 32. Global Lung Cancer Diagnostics Sales Market Share by Application (2019-2024)
Table 33. Global Lung Cancer Diagnostics Sales by Application (2019-2024) & (M USD)
Table 34. Global Lung Cancer Diagnostics Market Share by Application (2019-2024)
Table 35. Global Lung Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
Table 36. Global Lung Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 37. Global Lung Cancer Diagnostics Sales Market Share by Region (2019-2024)
Table 38. North America Lung Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Lung Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Lung Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 41. South America Lung Cancer Diagnostics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Lung Cancer Diagnostics Sales by Region (2019-2024) & (K Units)
Table 43. Global Lung Cancer Diagnostics Production (K Units) by Region (2019-2024)
Table 44. Global Lung Cancer Diagnostics Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Lung Cancer Diagnostics Revenue Market Share by Region (2019-2024)
Table 46. Global Lung Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Lung Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Lung Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Lung Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Lung Cancer Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Roche Diagnostics Lung Cancer Diagnostics Basic Information
Table 52. Roche Diagnostics Lung Cancer Diagnostics Product Overview
Table 53. Roche Diagnostics Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Roche Diagnostics Business Overview
Table 55. Roche Diagnostics Lung Cancer Diagnostics SWOT Analysis
Table 56. Roche Diagnostics Recent Developments
Table 57. BioMйrieux Lung Cancer Diagnostics Basic Information
Table 58. BioMйrieux Lung Cancer Diagnostics Product Overview
Table 59. BioMйrieux Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. BioMйrieux Business Overview
Table 61. BioMйrieux Lung Cancer Diagnostics SWOT Analysis
Table 62. BioMйrieux Recent Developments
Table 63. Qiagen Lung Cancer Diagnostics Basic Information
Table 64. Qiagen Lung Cancer Diagnostics Product Overview
Table 65. Qiagen Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Qiagen Lung Cancer Diagnostics SWOT Analysis
Table 67. Qiagen Business Overview
Table 68. Qiagen Recent Developments
Table 69. Advpharma Lung Cancer Diagnostics Basic Information
Table 70. Advpharma Lung Cancer Diagnostics Product Overview
Table 71. Advpharma Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Advpharma Business Overview
Table 73. Advpharma Recent Developments
Table 74. AIT Austrian Institute of Technology Lung Cancer Diagnostics Basic Information
Table 75. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product Overview
Table 76. AIT Austrian Institute of Technology Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. AIT Austrian Institute of Technology Business Overview
Table 78. AIT Austrian Institute of Technology Recent Developments
Table 79. Courtagen Life Sciences Lung Cancer Diagnostics Basic Information
Table 80. Courtagen Life Sciences Lung Cancer Diagnostics Product Overview
Table 81. Courtagen Life Sciences Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Courtagen Life Sciences Business Overview
Table 83. Courtagen Life Sciences Recent Developments
Table 84. DiagnoCure Lung Cancer Diagnostics Basic Information
Table 85. DiagnoCure Lung Cancer Diagnostics Product Overview
Table 86. DiagnoCure Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. DiagnoCure Business Overview
Table 88. DiagnoCure Recent Developments
Table 89. BioMark Diagnostics Lung Cancer Diagnostics Basic Information
Table 90. BioMark Diagnostics Lung Cancer Diagnostics Product Overview
Table 91. BioMark Diagnostics Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. BioMark Diagnostics Business Overview
Table 93. BioMark Diagnostics Recent Developments
Table 94. Mayo Clinic Lung Cancer Diagnostics Basic Information
Table 95. Mayo Clinic Lung Cancer Diagnostics Product Overview
Table 96. Mayo Clinic Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Mayo Clinic Business Overview
Table 98. Mayo Clinic Recent Developments
Table 99. HalioDx SAS Lung Cancer Diagnostics Basic Information
Table 100. HalioDx SAS Lung Cancer Diagnostics Product Overview
Table 101. HalioDx SAS Lung Cancer Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. HalioDx SAS Business Overview
Table 103. HalioDx SAS Recent Developments
Table 104. Global Lung Cancer Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 105. Global Lung Cancer Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 106. North America Lung Cancer Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 107. North America Lung Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 108. Europe Lung Cancer Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 109. Europe Lung Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 110. Asia Pacific Lung Cancer Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 111. Asia Pacific Lung Cancer Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 112. South America Lung Cancer Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 113. South America Lung Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 114. Middle East and Africa Lung Cancer Diagnostics Consumption Forecast by Country (2025-2032) & (Units)
Table 115. Middle East and Africa Lung Cancer Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 116. Global Lung Cancer Diagnostics Sales Forecast by Type (2025-2032) & (K Units)
Table 117. Global Lung Cancer Diagnostics Market Size Forecast by Type (2025-2032) & (M USD)
Table 118. Global Lung Cancer Diagnostics Price Forecast by Type (2025-2032) & (USD/Unit)
Table 119. Global Lung Cancer Diagnostics Sales (K Units) Forecast by Application (2025-2032)
Table 120. Global Lung Cancer Diagnostics Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Lung Cancer Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Diagnostics Market Size (M USD), 2019-2032
Figure 5. Global Lung Cancer Diagnostics Market Size (M USD) (2019-2032)
Figure 6. Global Lung Cancer Diagnostics Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Diagnostics Market Size by Country (M USD)
Figure 11. Lung Cancer Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Lung Cancer Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Lung Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Lung Cancer Diagnostics Market Share by Type
Figure 18. Sales Market Share of Lung Cancer Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Lung Cancer Diagnostics by Type in 2023
Figure 20. Market Size Share of Lung Cancer Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Lung Cancer Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lung Cancer Diagnostics Market Share by Application
Figure 24. Global Lung Cancer Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Lung Cancer Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Lung Cancer Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Lung Cancer Diagnostics Market Share by Application in 2023
Figure 28. Global Lung Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Lung Cancer Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Lung Cancer Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Lung Cancer Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Lung Cancer Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Lung Cancer Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Lung Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Lung Cancer Diagnostics Sales Market Share by Region in 2023
Figure 44. China Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Lung Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Lung Cancer Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Lung Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Lung Cancer Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Lung Cancer Diagnostics Production Market Share by Region (2019-2024)
Figure 62. North America Lung Cancer Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Lung Cancer Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Lung Cancer Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 65. China Lung Cancer Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Lung Cancer Diagnostics Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Lung Cancer Diagnostics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Lung Cancer Diagnostics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Lung Cancer Diagnostics Market Share Forecast by Type (2025-2032)
Figure 70. Global Lung Cancer Diagnostics Sales Forecast by Application (2025-2032)
Figure 71. Global Lung Cancer Diagnostics Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Lung Cancer Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Diagnostics Market Size (M USD), 2019-2032
Figure 5. Global Lung Cancer Diagnostics Market Size (M USD) (2019-2032)
Figure 6. Global Lung Cancer Diagnostics Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Diagnostics Market Size by Country (M USD)
Figure 11. Lung Cancer Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Lung Cancer Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Lung Cancer Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Lung Cancer Diagnostics Market Share by Type
Figure 18. Sales Market Share of Lung Cancer Diagnostics by Type (2019-2024)
Figure 19. Sales Market Share of Lung Cancer Diagnostics by Type in 2023
Figure 20. Market Size Share of Lung Cancer Diagnostics by Type (2019-2024)
Figure 21. Market Size Market Share of Lung Cancer Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lung Cancer Diagnostics Market Share by Application
Figure 24. Global Lung Cancer Diagnostics Sales Market Share by Application (2019-2024)
Figure 25. Global Lung Cancer Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Lung Cancer Diagnostics Market Share by Application (2019-2024)
Figure 27. Global Lung Cancer Diagnostics Market Share by Application in 2023
Figure 28. Global Lung Cancer Diagnostics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Lung Cancer Diagnostics Sales Market Share by Region (2019-2024)
Figure 30. North America Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Lung Cancer Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Lung Cancer Diagnostics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Lung Cancer Diagnostics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Lung Cancer Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Lung Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Lung Cancer Diagnostics Sales Market Share by Region in 2023
Figure 44. China Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Lung Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Lung Cancer Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Lung Cancer Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Lung Cancer Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Lung Cancer Diagnostics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Lung Cancer Diagnostics Production Market Share by Region (2019-2024)
Figure 62. North America Lung Cancer Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Lung Cancer Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Lung Cancer Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 65. China Lung Cancer Diagnostics Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Lung Cancer Diagnostics Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Lung Cancer Diagnostics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Lung Cancer Diagnostics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Lung Cancer Diagnostics Market Share Forecast by Type (2025-2032)
Figure 70. Global Lung Cancer Diagnostics Sales Forecast by Application (2025-2032)
Figure 71. Global Lung Cancer Diagnostics Market Share Forecast by Application (2025-2032)
